sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Biopharmaceutical Contract Manufacturing Market Scope And Analysis

  • Report Code : TIPRE00005512
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 151
Buy Now

Biopharmaceutical Contract Manufacturing Market Analysis, Size, and Growth (2025-2031)

Buy Now

Biopharmaceutical Contract Manufacturing Market Report Biopharmaceutical Contract Manufacturing Market Size and Share Biopharmaceutical Contract Manufacturing Market Scope and Analysis

Biopharmaceutical Contract Manufacturing Market Report Scope

Report Attribute Details
Market size in 2024 US$ 40.99 Billion
Market Size by 2031 US$ 101.05 Billion
Global CAGR (2025 - 2031) 13.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product Type
  • Biologics
  • Biosimilar
By Source
  • Microbial
  • Mammalian
By Application
  • Commercial
  • Clinical
By Therapeutic Area
  • Oncology
  • Autoimmune Disorders
  • Respiratory Disorders
  • Metabolic Disorders
  • Neurology
  • Infectious Diseases
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Boehringer Ingelheim International GmbH
  • Thermo Fisher Scientific Inc
  • Lonza Group AG
  • Merck KGaA
  • AbbVie Inc
  • General Electric Co
  • Samsung Biologics Co Ltd
  • WuXi Biologics Inc
  • Inno Bio Ventures Sdn Bhd
  • Ajinomoto Co Inc